OOIR: Observatory of International Research

Papers

(The median citation count of Clinics in Liver Disease is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Navigating the Management of Hepatocellular Carcinoma	427
Forthcoming Issues	78
Forthcoming Issues	46
Copyright	43
Special Population	43
Forthcoming Issues	39
Contributors	38
Artificial Intelligence, Large Language Models, and Digital Health in the Management of Alcohol-Associated Liver Disease	38
Forthcoming Issues	34
Artificial Intelligence and Machine Learning Applications in Liver Disease	31
Recurrent and De Novo Liver Disease After Liver Transplantation	31
Primary Biliary Cholangitis	30
Contents	24
The Role of Liver Transplantation in Hepatocellular Carcinoma	24
Overview of New Targets for Hepatitis B Virus	23
Preface	23
Advances in Viral Hepatitis B and D: Moving Toward the Goals of Elimination	22
Clinical Vignettes Illustrating the Spectrum of Hepatocellular Carcinoma Presentation and Treatment	22
What is the Path Forward to Treat Hepatitis Delta Virus?	21
Pathogenesis of Alcohol-Associated Liver Disease	20
Preface	19
Consultations in Liver Disease	19
Nonalcoholic Fatty Liver Disease in Latin America and Australia	18
The Diagnostic Pathway for Patients with Cholestatic Liver Disease	17
Portal Hypertension and its Complications	17

Primary Biliary Cholangitis	17
Evaluation and Management of Pruritus in Primary Biliary Cholangitis	17
Copyright	16
Alcohol-Associated Liver Disease	16
Contributors	16
Substance Use Disorders and Interprofessional Management in the Pre and Post Liver Transplant Settings	15
Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America	14
Minimal Hepatic Encephalopathy	14
Association of Metabolic Dysfunction-Associated Steatotic Liver Disease with Extrahepatic Cancers and Sarcopenia	14
Targeting Hepatitis B Virus DNA Using Designer Gene Editors	14
Primary Sclerosing Cholangitis	13
Recent Advances in Primary Biliary Cholangitis Treatment	13
Advances in Cholestatic Liver Disease	13
General Hepatology Concerns for the Patient with Cholestatic Liver Disease	13
Biliary Atresia in Children	12
Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease	12
Emerging Pharmacologic Treatments for Alcohol-Associated Hepatitis	12
Pharmacologic Management of Hepatic Encephalopathy	11
The Liver in Diabetes and Metabolic Syndrome	11
Copyright	11
Beyond the Liver	11
Current and Next-Generation Therapeutics in Hepatology	11
Noninvasive Fibrosis Testing in Chronic Liver Disease Including Caveats	11
Treatment of Primary Sclerosing Cholangitis Including Transplantation	10
Hepatitis B and C in Children	10
Hepatocellular Carcinoma	10
Alcohol Use Disorder	10
Copyright	10
Prognostic Scoring Systems in Primary Biliary Cholangitis	10
The Liver in Hematologic Malignancies	10
Treatment of Modifiable Risks in Metabolic Dysfunction-Associated Steatotic Liver Disease	10
Novel Therapies in Primary Biliary Cholangitis	10
Navigating Hepatocellular Carcinoma	9
Contents	9
Overview of Progressive Familial Intrahepatic Cholestasis	9
Acute Alcoholic Hepatitis	9
Preventing Readmissions for Hepatic Encephalopathy	9
Contents	9
Chronic Hepatitis B	9
Forthcoming Issues	9
Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean	8
Alagille Syndrome	8
Primary Biliary Cholangitis	8
Disparities in Alcohol-Related Liver Disease	8
Hepatic Encephalopathy	8
Noninvasive Evaluation of Fibrosis and Portal Hypertension in Primary Biliary Cholangitis	8
Genetics of Primary Biliary Cholangitis	8
Renal Insufficiency in Patients with Cirrhosis	8
Contents	8
Disease Modulating Agents in Cirrhosis	8

Amyloidosis and the Liver	8
State of the Art	8
Portal Hypertension and its Complications: A Guided Tour of the Post–Baveno 7 Landscape	8
Alcohol-Related Liver Disease	8
What Is the Real Epidemiology of Hepatitis D Virus and Why so Many Mixed Messages?	8
Chronic Hepatitis B Virus and Hepatitis D Virus	7
Genetic Markers Predisposing to Nonalcoholic Steatohepatitis	7
Genetic Cholestasis Syndromes	7
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease	7
Hepatic Encephalopathy in Acute-on-Chronic Liver Failure	7
Contributors	7
Systemic Complications of Primary Biliary Cholangitis	7
Phenotypes of Primary Sclerosing Cholangitis and Differential Diagnosis	7
Autoimmune Hepatitis	6
Liver Transplantation in Acute-on-Chronic Liver Failure	6
Metabolic Dysfunction-Associated Steatotic Liver Disease	6
Contributors	6
Future Treatment Options and Regimens for Nonalcoholic Fatty Liver Disease	6
Recurrence of Primary Biliary Cholangitis and Primary Sclerosing Cholangitis after Liver Transplantation	6
Autoimmune Markers in Primary Biliary Cholangitis	6
Contents	5
The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis	5
Hepatopulmonary Syndrome and Portopulmonary Hypertension	5
Diagnosis of Autoimmune Hepatitis	5
Portopulmonary Hypertension	5
Copyright	5
An Update on Pediatric Acute Liver Failure	5
Role of Liver Biopsy in Clinical Trials and Clinical Management of Nonalcoholic Fatty Liver Disease	4
Wilson Disease in Children	4
Epidemiology and Health Care Burden of Alcohol Use Disorder	4
Role of Liver Transplant in Primary and Secondary Liver Malignancies	4
Medical Treatments and Outcomes in Acute Alcohol-Related Hepatitis	4
Integrated Multidisciplinary Care Model to Manage the Dual Pathology of Alcohol Use Disorder and of Liver Disease	4
Currently Approved and Future Regimens for Metabolic Dysfunction-Associated Steatohepatitis	4
Hepatic Resection for Hepatocellular Carcinoma	4
Post-Transplant Management and Complications of Autoimmune Hepatitis, Primary Biliary Cholangitis, and Primary Sclerosing Cholangitis including Disease Recurrence	4
Current Focus and Innovation in Liver Transplantation	4
Cholangiocarcinoma Surveillance Recommendations in Patients with Primary Sclerosing Cholangitis	3
Primary Sclerosing Cholangitis	3
Liver Transplantation in Alcohol-Associated Liver Disease	3
Contents	3
The Clinical Spectrum and Manifestations of Acute-on-Chronic Liver Failure	3
Autoimmune Hepatitis	3
Hepatic Encephalopathy	3
Bacterial Infections Involving the Liver	3
Contributors	3
Embolic and Ablative Therapy for Hepatocellular Carcinoma	3
Liver Transplantation: A Decade of Progress	3
Nonalcoholic Fatty Liver Disease in Asia, Africa, and Middle East Region	3
Surgical Considerations in Portal Hypertension	3
The “B and D” Times, They Are A-Changin’	3
Pediatric Liver Disease	3
Clinics in Liver Disease: Update on Nonalcoholic Steatohepatitis	3
Update on Non-Alcoholic Steatohepatitis	2
The Liver in Sepsis	2
Classification and Epidemiologic Aspects of Acute-on-Chronic Liver Failure	2
Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma	2
Endohepatology	2
Copyright	2
Special Populations	2
The Evolving Landscape of Primary Biliary Cholangitis	2
Noninvasive Testing for Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis	2
Epidemiology of Alcohol-Associated Liver Disease Including Increasing Burden in Young Adults and Females Especially Since Covid-19 Pandemic	2
Roles of Radiological Tests in Clinical Trials and the Clinical Management of Nonalcoholic Fatty Liver Disease	2
Copyright	2
Mechanisms of Disease and Multisystemic Involvement	2
Managing Alcohol Use Disorder in Alcohol-Related Liver Disease	2
Alpha-1 Antitrypsin Deficiency Liver Disease	2
Pediatric Liver Diseases	2
Research Priorities for Precision Medicine in NAFLD	2
Therapies and Pipeline for Hepatitis B and Hepatitis D	2
Bacterial Infections in Acute on Chronic Liver Failure	2
Prognostic Models in Acute-on-Chronic Liver Failure	2
The Diagnosis and Staging of Hepatocellular Carcinoma	2
Liver Failure from Alcohol Takes on Several Forms	2
Copyright	2
Copyright	2
Cerebral Aspects of Portal Hypertension	2
Copyright	2
Contents	2

Radiological and Surgical Treatments of Portal Hypertension	2
Gut Bacteria in Alcohol-Associated Liver Disease	1
Forthcoming Issues	1
Advances in Pediatric Liver Diseases	1
Metabolic Dysfunction-Associated Steatohepatitis in the Middle East: Clinical Challenges and Strategies to Bridge the Gap	1
The Pathophysiology of Portal Hypertension	1
The Role of Palliative Care in the Management of Patients with Hepatocellular Carcinoma	1
Novel Therapeutics for Hepatocellular Carcinoma	1
Treatment of Alcohol Use Disorder	1
Infectious Complications of Portal Hypertension	1
Contributors	1
Diagnostic Tests in Primary Sclerosing Cholangitis	1
Hepatocellular Carcinoma in Primary Biliary Cholangitis	1
Treatment of Primary Biliary Cholangitis including Transplantation	1
Contents	1
Contents	1
Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic Fatty Liver Disease	1
Evaluation of Patients with Liver Disease before Nonhepatic Surgery	1
Noninvasive Assessment of Portal Hypertension	1
Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa	1
Special Population	1
Impact of Alcohol Use on Nonalcohol-Related Liver Diseases	1
Contents	1
Liver Regeneration in Acute on Chronic Liver Failure	1
Primary Biliary Cholangitis in Males	1
Current Status and Future Directions in the Pharmacologic Management of Cirrhosis	1
The Liver in Systemic Disease	1
Treatment of Autoimmune Hepatitis	1
Immunologic Responses and the Pathophysiology of Primary Biliary Cholangitis	1
Systemic Therapy for Hepatocellular Carcinoma	1
Contents	1